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In a world with a constantly growing and aging 
population, health is a precious asset. Presently, with 
machine learning (ML), a technological change is 
taking place that could provide high quality healthcare 
and especially, improve efficiency of medical 
diagnostics in clinics. However, ML needs to be deeply 
integrated in clinical routines which highly differs from 
the integration of previous health IT given the specific 
characteristics of ML. Since existing literature on the 
adoption of ML in medical diagnostics is scarce, we set 
up an explorative qualitative study based on a 
conceptual basis consisting of the technological-
organizational-environmental framework (TOE) and 
the healthcare specific framework of non-adoption, 
abandonment, scale-up, spread, and sustainability 
(NASSS). By interviewing experts from clinics and 
their suppliers we were able to connect both 
frameworks and identify influencing factors specific to 
the adoption process of ML in medical diagnostics.  
 
1. Introduction  
 
The ongoing digitalization influences the society 
and business world, including the healthcare sector as a 
whole. For instance, the integration of health 
information technologies (HIT) in clinics such as 
electronic health records enables significant 
improvements in therapy, rehabilitation, or diagnostics 
[21]. However, this new technological opportunities 
also lead to challenges within clinics: Physicians have 
to deal with an ever-increasing amount of patient’s 
data created by digitized systems [4]. In addition, 
clinics currently face major societal issues: The high 
number of aging-related diseases caused by 
demographic change is—for example—further 
increased by the global COVID-19 pandemic crisis, so 
that the resources of medical personnel become 
progressively strained [27]. Artificial intelligence (AI) 
as the “science and engineering of making intelligent 
machines, especially intelligent computer programs” 
[31:2] could help solving such challenges and makes it 
possible to technically solve tasks that were previously 
reserved for human intelligence [38]. Especially, 
machine learning (ML) as a subfield of AI is currently 
one of the most rapidly growing technological 
opportunities. Thus, in this research paper, we focus on 
ML, which enables information systems (IS) to 
improve themselves automatically through training 
experience [8, 23]. ML systems have the enormous 
potential to process complex patient data (e.g. medical 
images or text data) effectively, find hidden patterns in 
symptoms, and link them to possible diseases. In this 
regard, the use of ML systems for diagnostics could 
enable more profound and efficient diagnoses and 
could thus be decisive for life or death [18, 42]. 
However, ML systems also pose challenges, which 
prevents a wide-spread implementation in clinics so far 
[24]. This is particularly the case as ML systems differ 
from other HIT as they are able to adapt their behavior 
over time, operate as black boxes, derive results 
statistically, and can thus lead to erroneous decisions 
[8]. 
IS research has recently begun to investigate the 
chances and challenges of ML in healthcare. For 
example, it has been analyzed what ML systems can 
contribute to improve medical processes and, in 
particular, medical diagnostics [e.g. 19, 25]. 
Furthermore, technical research is being done to 
demonstrate the feasibility of ML systems’ application 
in medicine [e.g. 3, 29]. However, prior studies have 
not yet contributed sufficiently to an understanding of 
clinics’ adoption process of ML systems. In that 
regard, our research aims to identify: Which specific 
factors influence the readiness of clinics to adopt ML 
systems and subsequently implement such systems for 
medical diagnostics? To answer this question, we 
conducted a qualitative study based on interviews with 
experts working for clinics or their suppliers. In order 
to sort our key findings, we refer to the technological-
organizational-environmental (TOE) framework and 
the framework of non-adoption, abandonment, scale-
up, spread and sustainability (NASSS) as a conceptual 
basis [12, 17].  







2. Theoretical background 
 
ML systems are based on algorithms capable of 
extrapolating patterns from data [39]. The acquired 
patterns can then be applied to new data in order to 
make, for example, classifications. As a consequence, 
ML systems are able to solve tasks without receiving 
explicit instructions but by learning from training 
examples. These examples can either be labelled (e.g. 
symptoms and related condition) or without any 
annotation (e.g. symptoms), resulting in a respective 
supervised or unsupervised ML problem [8]. Due to 
the data-based learning approach, an inherent property 
of ML systems is that they can be adapted to new data 
and evolve over time if being retrained [39]. 
Reaching from prediction of patient traffic in 
clinics to support of therapies: ML systems can help 
solving various problems in medicine [42, 43]. 
However, one of the most prominent areas of 
application in research and practice are medical 
diagnostics [e.g. 35, 41]. In this context, ML systems 
(and especially deep neural networks) can help to 
identify patterns in medical data (e.g. in medical scans, 
pathology slides, electrocardiograms) and sort possible 
conditions according to their likelihood [18, 44]. A 
distinction can be made whether ML serves to take 
over entire areas of responsibility from doctors or to 
support them in their decision-making process. In the 
near future, ML systems will mainly be used as an 
intelligent decision support rather than to automate 
medical diagnostics fully [e.g. 18, 25]. In this sense, 
current practical examples such as Isabel Health (an 
ML based symptom checker) show that more and more 
of such assistive ML systems are presently finding 
their way into clinics [46]. These systems raise the 
hope of making medical diagnostics faster, more 
efficient, and consistent and thus more valuable since 
they are able to compare patients’ data with a database 
that is larger than any physician’s experience [18, 42]. 
However, the introduction of ML systems in clinics 
also poses major challenges as these systems highly 
differ from conventional HIT. ML systems learn from 
high volumes of data, instead of being explicitly 
programmed [39]. It is therefore imperative to share 
data across clinics to enable profound training of the 
ML system [18]. Provided that ML systems are based 
on appropriate data, they are able to prepare high 
stakes diagnostic decisions (e.g. by suggesting possible 
conditions) [25]. ML systems derive these solutions 
based on statistical methods, which leads to several 
consequences: Modern ML systems are not only 
becoming increasingly opaque, they also never lead to 
100% accuracy [8, 25]. These properties are 
particularly problematic in a medical setting where 
patients’ lives depend on a profound diagnosis and the 
correct functionality of the ML system should be 
ensured at any time [25]. Given the specific 
characteristics of ML systems, a wide-spread adoption 
in clinics has not been achieved so far, requiring more 
detailed investigation by research [24].  
In order to gain an overview of existing literature 
regarding the adoption process of ML systems in 
clinics, a systematic literature review was conducted 
and published by the authors [37]. Looking at the 
articles identified, it becomes clear that most of the 
publications do not include primary empirical studies 
to identify factors influencing the adoption process of 
ML systems in clinics. Furthermore, none of the 
publications based their research on pertinent theories 
in order to develop a holistic understanding of the 
adoption process in clinics. Even though, ML systems 
are highly relevant in medicine, there is thus a lack of 
empirical and theoretically profound research. Against 
this background, an investigation of the challenges 
related to the adoption process of ML systems in 
clinics is desirable. To gain deeper insights into this 
research field, it is important to differentiate that the 
adoption process of innovations in organizations 
consists of two main phases comprising: (1) The initial 
readiness for a technology and (2) its subsequent 
implementation within the organization [50]. Both 
steps are highly relevant to the success of a technology 
within an organization and should be considered as 
dependent from each other [45]. The two-stage 
adoption process is a complex, multi-dimensional 
process that is difficult to represent using a single 
theory. In line with the recommendations of Mayer and 
Sparrowe (2013), we therefore base our research on 
“two theories to address what neither theory could 
[explain] independently” [30:917]. We thus utilize two 
frameworks to investigate the factors that influence a 
clinic’s process from (1) the first readiness to (2) the 
implementation of ML systems. Accordingly, we chose 
to employ both (1) the TOE framework developed by 
DePietro et al. (1990) [12] and (2) the NASSS 
framework [17] as a conceptual basis. 
The TOE framework is widely used in IS research 
to understand the readiness of an organization to adopt 
a new technological innovation [e.g. 1, 47]. In this 
regard, it considers three domains: The technological, 
organizational, and the environmental context. Each 
context, in turn, comprises several factors that specify 
on the considered domain. Those are for example the 
characteristics of the investigated technology 
(technological context), the existing infrastructure 
within an organization (organizational context), or 
governmental regulations concerning a technology 
(environmental context) [12]. In the last few years, 
clinics are increasingly faced with technological 




relevant to them [2]. In that regard, several studies 
have used and adapted the TOE framework to explain 
the factors that influence the readiness of a clinic to 
adopt an HIT, although the framework was not 
originally established for the healthcare industry [e.g. 
22, 28]. Thus, we consider the theoretical framework to 
be a useful starting point to investigate what enables 
clinics to prepare for the adoption of ML systems.  
Presently, adoption research in health informatics 
started to look beyond the mere readiness and towards 
the implementation phase after the adoption actually 
took place [17]. In this context, ML systems own 
highly specific characteristics that will necessitate a 
significant change in the organization’s structure and 
working routines in the long run [8, 25]. Therefore, the 
implementation phase after the first readiness to adopt 
is just as decisive for the success of ML systems in 
clinics as the previous one. To capture this, we 
included the NASSS technology implementation 
framework as a second conceptual basis. NASSS has 
primarily been developed for the healthcare context by 
combining established health- and social care 
frameworks and can be used to analyze the 
implementation phase of an HIT. It includes seven 
domains such as the condition to be diagnosed and 
treated, the demand- and supply-side value proposition 
associated with an HIT, and the adopter system 
consisting of patients, their relatives and medical staff. 
Furthermore, it explicitly conceptualizes on the 
embedding and adaptation of the HIT within a clinic 
over time [17]. In summary, the factors of NASSS help 
to complement the TOE framework to account for the 
whole adoption process of a HIT in clinical processes. 
Since ML systems differ significantly from existing 
technologies and it is not sufficient to rely on either the 
basic TOE or NASSS framework [49], we seek to 
combine, adapt, and extend both frameworks in the 
following to gain a profound understanding about the 
specific factors that enable clinics to put ML systems 
into clinical practice.  
 
3. Qualitative research methodology  
 
Our overarching goal was to identify the factors 
that are specific to the adoption process of ML systems 
in clinics and are not yet sufficiently covered by 
existing theories. We thus followed the steps of 
directed content analysis in order to extend the 
established conceptual framework based on TOE and 
NASSS. In that regard, we used both frameworks as a 
starting point that were integrated, adapted, and 
expanded taking into account the qualitative data [20].  
To analyze and understand the highly complex 
process from a first readiness to a routine use of ML 
systems, an in-depth analysis was necessary. We 
therefore employed a qualitative approach to “see the 
world through the eyes of the actors doing the acting” 
[16:17] and conducted interviews with highly involved 
experts (N=15). We formulated a semi-structured 
interview guideline to lead the conversation and to 
ensure that all relevant questions are posed. Due to the 
qualitative approach, the guideline was kept open and 
flexible to allow adaptations to the respective interview 
partner, one’s position and knowledge base [33].  
The qualitative data were collected from May to 
October 2019 within Germany. In order to identify 
suitable participants, we have searched for experts in 
social networks, on clinic websites, and at relevant 
conferences on ML in medicine. Qualified interviewed 
experts (N=15) were chosen, who have detailed 
knowledge of clinical processes, experience with ML 
systems, and are involved in the respective decision-
making processes [7]. We consider the additional 
supplier perspective to be particularly useful to 
triangulate the data [9]. The various experts are clinics’ 
managers, physicians, and managers of diagnostic HIT 
suppliers. While three of the interviewed experts were 
physicians, six hold a hybrid position (i.e. physicians 
with additional leadership responsibilities), and six 
were full-time managers with medical education. As 
shown in Table 1, different medical disciplines were 
considered in the interviews (e.g. radiology, pathology, 
internal medicine) in order to allow for different 
perspectives on medical diagnostic processes (e.g. 
interpretation of medical scans, pathology slides, 
electrocardiograms) and obtain more generalizable 
results [5]. All experts had in common that they had 
prior knowledge on ML systems due to research work, 
pertinent projects, or product development processes. 
Table 1: Study participant overview 
 Position  Specialty Exp. in yr. 
Clinics (C): Key informants of clinics  
*: Physician with leadership responsibilities 
01 Physician Radiology 3 
02 Physician Radiology 15 
03 Physician Radiology 8 
04 Physician*  Neuro-radiology  9 
05 Physician*  Internal medicine  19 
06 Physician*  Internal medicine  35 
07 Physician* Pathology  18 
08 Physician* Radiology 37 
09 Physician* Gynecology 40 
10 CTO Cardiology 8 
11 CTO Biomedicine 20  
12 Director Internal medicine  12 
HIT Supplier (S): Key informants of clinics’ HIT 
supplier companies 
01 Director  Nephrology 20 
02 Director Biomedicine 22 




Participants work for several clinics and HIT 
suppliers (i.e. nine different clinics, three HIT 
suppliers). While three clinics are privately financed, 
the others are public. Furthermore, all clinics and 
suppliers are currently running projects related to ML. 
On average, each expert interview lasted 49 minutes 
and took place in private space. The interviews were 
audio recorded and transcribed after mutual agreement. 
In two interviews only, notes were taken as the 
participant refused audio recording. The transcripts 
were analyzed with the help of NVivo 12 software. We 
applied an iterative multi-cycle coding process that is 
in line with qualitative content analysis and that 
consisted of two coding cycles, between which we 
moved back and forth [40]. The first cycle comprised 
three different types of coding: Using attribute coding 
enabled us to receive descriptive information 
concerning the participant. Hypothesis coding was 
employed to consider the prespecified conceptual 
framework (i.e. TOE and NASSS) and to examine the 
suitability of existing factors regarding the adoption 
process (e.g. clinic’s size). In contrast, the descriptive 
coding approach allowed us to identify new aspects 
that go beyond the conceptual framework by 
disregarding formerly identified factors. Since the 
coding procedure during the first cycle has led to a 
large number of factors, we used pattern coding within 
the second coding cycle to pull together the codes into 
a smaller number of constructs [40].  
During the research process, we employed several 
practices to obtain rigor and trustworthiness. To begin 
with, we defined a clear research question and 
conceptual framework that we used as input for our 
research design. Furthermore, we followed a 
theoretical sampling approach by iterating between 
data collection and analysis until theoretical saturation 
was reached after the 15th interview [15]. The resulting 
amount of interviews is comparable to other qualitative 
studies in IS (healthcare) research [e.g. 6, 19]. Besides, 
a multi-researcher triangulation took place. In that 
sense, coding was intensively discussed between the 
authors during the data analysis [9]. We also decided to 
include the voice of participants and thus quoted 
directly from the interviews while presenting our 
findings [10:182]. 
 
4. Results and discussion of findings  
 
As diagnostic procedures can differ within the 
different medical specialties, the data analysis focuses 
on common factors that affect the adoption of ML 
systems for diagnostics in clinics and can be derived 
across all disciplines. The key findings are structured 
according to the TOE and NASSS framework in order 
to describe the holistic adoption process of ML 
systems. An integrative overview of all these factors 
can be seen in Figure 1. In this regard, the first three 
propositions (abbreviated: P) refer to clinic’s readiness 
to adopt ML systems for diagnostics, while P4-6 apply 
to the implementation phase. However, P7 shows the 
relevance of patient data for both adoption phases. 
 
Figure 1: Integrative overview of the findings 
In the following, we present and discuss the results 
of our data analysis. For this purpose, we structure our 
findings according to the domains technological, 
organizational, and environmental context as well as 
the adopter system, condition, value proposition, and 
the stand-alone domain patient data.  
Technological context. The characteristics of a 
technology are a factor that is already considered 
within the original TOE framework [12]. Nevertheless, 
as outlined earlier, ML systems encompass several 
highly specific characteristics, that cannot be compared 
to other technologies. Therefore, the existing general 
factor “characteristics” is not sufficient to capture the 
properties of ML and has to be specified further.  
As one sub-factor of ML characteristics, the 
interviewees point out the ‘lack of transparency’ of ML 
systems as a major obstacle for clinic’s readiness to 
adopt ML systems. ML systems based on neural 
networks can consist of multiple processing layers and 
up to millions of numerical weights hampering the 
comprehensibility of ML systems to humans [8]. 
Especially in high-stakes decision-making processes 
such as medical diagnostics, this can lead to major 
issues. In this context, the experts state that physicians 
need to know exactly, which are the critical features 
considered by ML systems and how identified patterns 
lead to conclusions to be able to assess the ML 
system’s recommendation and suggest an appropriate 
therapy. One of the experts underlines this aspect: 
“You will never make these existential decisions 
dependent on a black box, where it is not possible to 
understand what led to the recommendation” (C-06). 
Another sub-factor of ML characteristics is the ‘ability 
to adapt’ their functioning if being retrained on novel 




system is transferred to another context (e.g. another 
clinic) or needs to be retrained after some time as for 
example new medical research results are gained or 
patients’ demographic structure shifts. Clinics thus 
have to deal with an opaque system that is able to 
change its reasoning, making the outcome of a ML 
system unpredictable. Accordingly, experts see the 
adaptability of ML systems as another factor that has to 
be addressed by clinics (S-01, S-03). In order to 
prepare for the adoption of ML systems, clinics need to 
have a clear strategy in place on how to cope with the 
opacity and adaptability of self-learning ML systems. 
We thus state our first proposition: 
P1: The characteristics of ML systems (i.e. lack of 
transparency, adaptability) will impede the readiness 
of clinics to adopt ML systems. 
Organizational context. Looking at the 
organizational context domain, three factors emerged 
during the interviews: size of clinic, medical directors’ 
ML support and clinic’s resources for ML.  
The size of a clinic is similar to an existing TOE 
factor that was also considered relevant in the context 
of ML systems. In this sense, experts emphasized that 
small clinics have usually less resources compared to 
large clinics, which could hamper their readiness to 
adopt ML systems (C-11). In addition, larger clinics 
care for a larger number of different patients and thus 
have access to higher amounts of patient data which is 
needed to train ML systems appropriately (S-01). 
Furthermore, experts state that the first decision to 
adopt ML systems for diagnostic processes needs to be 
supported by clinic’s medical directors to achieve 
financial and non-financial support for the new 
technology (C-03). In this regard, ML systems for 
medical diagnostics affect the core business of clinics 
and thus have a strategic relevance [49]. As medical 
directors develop the clinic’s strategy, they are 
responsible for paving the way regarding the readiness 
of clinics to adopt ML systems. This is in line with 
prior research that states the significance of medical 
directors’ support regarding the readiness of clinics for 
strategically relevant HITs [28, 47]. 
One of the most frequently stated factors within the 
organizational context are clinic’s resources to get 
ready to adopt ML systems. This factor incorporates 
three sub-factors which are either in line with the 
original TOE framework (i.e. ‘clinic’s technical 
infrastructure’) or newly added (i.e. ‘financing 
structure’, ‘expertise in medicine and data science’). In 
line with existing literature [34], some of the experts 
report that clinics frequently rely on a wide range of 
clinical legacy systems, which are often proprietary to 
the suppliers, not connected, and based on obsolete 
hardware: “The primary challenge […] is that the 
clinic usually consists of […] million proprietary 
systems that are not connected” (C-01). However, 
experts emphasize the importance of a high-
performance technical infrastructure that can 
efficiently access data from different sources to 
achieve readiness for ML systems’ adoption (C-01, C-
07). Therefore, clinic’s technical infrastructure could 
pose a major challenge for the introduction of ML 
systems.  
The interviewed experts furthermore point out the 
problem of the current financing structure of clinics, 
which leads to strict budgetary constraints (C-09). In 
this regard, an interviewee states that one part of their 
budget is assigned to daily costs such as medication. 
The other part of the budget can be used to purchase 
large-scale medical equipment like X-ray systems. 
Thus, the development and set-up of ML systems is not 
covered by either of the two parts and no specific ML 
budget can be claimed (C-06).  
Beyond that, there is a lack of personnel in clinics 
having both expertise in medicine and data science: 
“The shortage of medical specialists hits us twice as 
hard. We feel this at the medical professional side [...], 
but it is also very apparent at the technical side” (C-
10). Both fields of knowledge are regarded as highly 
important for the readiness to adopt ML systems by the 
experts (C-01, C-10, S-02). While a medical 
background can help to identify relevant training data 
or to assess the suggested conditions of the ML system, 
technical expertise is needed to realize and train ML 
systems, as presently, nearly no out-of-the-box ML 
systems exist for the application in medicine, requiring 
clinics to develop ML systems by themselves (C-01, C-
10, S-02). Therefore, specific expertise in the field of 
data science is needed in addition to the medical 
understanding in order to develop and set up ML 
systems in clinics. In sum, we propose: 
P2: A larger clinic size, medical directors’ ML 
support, and the availability of resources for ML (i.e. 
technical infrastructure, ML budget, expertise in the 
field of medicine and data science) will facilitate the 
readiness of clinics to adopt ML systems. 
Environmental context. With regard to the 
environmental context there are two relevant factors 
influencing the readiness to adopt ML systems: 
governmental regulations concerning ML and medical 
ethics. Governmental regulations are a factor already 
known from the original TOE framework. 
Nevertheless, the interviews revealed some 
particularities that are not covered by the general 
concept and are described below. Medical ethics is a 
factor that is not captured by TOE so far, but is 
identified through our study.  
In the field of medicine there are several 
governmental regulations which must be taken into 




following sub-factors could be identified: ‘medical 
approval of ML systems’, ‘accountability’, and the 
‘protection of sensitive personal data’. 
The experts draw attention to the fact that HIT 
offered on the market and used in clinics are subject to 
several laws. That includes the need for medical 
approval conducted by legal authorities or HIT 
suppliers themselves (C-03). In the USA, the Food and 
Drug Administration (FDA) is responsible for the 
admission of medical products. In Europe, the HIT 
suppliers themselves need to perform a conformity 
assessment procedure, e.g. based on the Medical 
Device Regulation (MDR) [14, 32]. As mentioned 
before, most ML systems are currently being 
developed by clinics themselves and have not 
undergone any approval process (C-03). However, 
legal approval of ML systems is not trivial, as the 
system can learn from new experience and adapt 
themselves as described above: “It is not obvious how 
evidence can be obtained for an [ML] model that 
differs significantly at the beginning, middle, and end 
of the study. If you want to approve a medical device 
today, you have to describe the intended use in detail” 
(S-01). This legal gap is also addressed by an official 
statement of the FDA that proposes a change to the 
current regulation to be able to approve adaptable ML 
systems [14]. A comparable position of the EU does 
not exist. Therefore, legal ambiguities could represent 
a hurdle for clinics to decide on the adoption of ML 
systems for diagnostics.  
In addition to the medical approval of a ML system, 
there is the question of accountability for diagnoses. 
The experts interviewed indicated that it is 
questionable who takes over responsibility, if the 
diagnosis that was prepared by an ML system is 
inaccurate (C-04, C-10). It is also unclear who can be 
held liable—the HIT provider, the clinic, or the 
physician who is providing the medical diagnosis. An 
expert underlines this aspect with the following words: 
„Then there are certainly […] legal problems, for 
example: who is responsible for the interpretation and 
possibly wrong results of the ML model?” (C-10). 
According to the current state of the art, ML systems 
cannot be held responsible for their output, since a 
registered physician is always obliged to validate and 
interpret the system’s results and to perform the final 
diagnosis (C-12). However, it would ease the decision 
of clinics to opt for ML system if there was a legal 
specification—especially if ML systems are 
increasingly able to automate steps of sensitive 
processes as diagnostics (C-10, C-11). 
Another sub-factor which could be identified as 
relevant for the initiation and adoption of ML systems 
for diagnostics is the protection of sensitive personal 
patient data. Patient data are considered as highly 
sensitive and are under special protection by national 
and international laws (C-02, S-02). For example, the 
General Data Protection Regulation (GDPR) in Europe 
only permits the processing of health data, if the 
patient explicitly accepts or if the clinic can provide 
particular reasons [13]. Thus, the respondents 
emphasize clinics’ concerns to obtain the necessary 
patient data to train the ML system (C-02, C-08). 
Using ML systems for diagnostic processes fueled 
medical ethical concerns among the interviewees. On 
the one hand, ML systems are able to improve the 
efficiency and effectivity of diagnostics (C-11, C-12, 
S-02). On the other hand, the suggestions provided by 
ML systems are deduced based on statistical methods 
recognizing patterns in patient data that can be biased 
(C-11). Furthermore, experts claimed that ML systems 
that are fed with patient data could determine whether 
a patient tends to develop a disease. This type of 
medical application would contradict the “patient's 
right not to know” (C-11). Summarizing these remarks, 
we set up the proposition: 
P3: Uncertainties in governmental regulations, strict 
requirements for the protection of sensitive patient 
data, and existing medical ethics will impede the 
readiness of clinics to adopt ML systems. 
Adopter system. The NASSS framework suggests 
that the successful implementation of ML systems is 
strongly influenced by the individuals who are 
supposed to use the system or affected by their 
suggestions. In this context, two ML specific factors 
turned out to be relevant according to the interviews, 
which further specify the factor: threat to physicians’ 
professional identity and patients’ ML reluctance. 
Since ML systems have the ability to solve tasks 
that were previously performed by humans, physicians 
might feel interchangeable in their job (C-03, C-05, S-
03). ML systems are trained on large sets of data, 
which exceed the experience of any single physician, 
setting new standards for medical diagnostics. In this 
regard, most experts are concerned that physicians 
could reject ML system for their daily work: "As a 
doctor who may have ten or 20 years of experience 
[...], would I like to be taught by a machine [...]?” (S-
03). These concerns have recently found its way into 
pertinent research, demonstrating the relevance of the 
topic [e.g. 25].  
The majority of the interviewees state the 
importance of patients’ view on the use of ML systems 
for medical diagnostics. Even though a physician is 
still involved in the decision-making process, patients 
might refuse the use of an ML system as the physician 
may be influenced by suggestions for possible 
conditions that are derived statistically and could be 
affected by biases. Furthermore, personal sensitive 




results. Therefore, experts state patients’ acceptance of 
ML systems as highly relevant for the implementation 
(C-02, C-04, C-10). We thus conclude: 
P4: The threat to the professional identity of 
physicians and patients’ reluctance towards ML 
systems will impede the implementation of ML 
systems in clinics. 
Condition. As specified within the NASSS 
framework, the patient’s nature of condition impacts 
the applicability of a technology. This does not only 
hold true for conventional HIT but is also stated for 
ML systems by the interviewed experts (C-02, C-07). 
Therefore, the nature of the condition and the 
according medical screening decides if ML can be 
applied to support a diagnostic process at all. Even 
though ML is considered a general-purpose technology 
[8], the experts see difficulties to use ML systems, for 
example, to recognize patterns of conditions in images 
of organs, which either differ vastly from person to 
person (e.g. female breast) or are in motion 
continuously (e.g. human bowel) (C-02). Thus, the use 
of ML systems will initially be limited to certain 
conditions: 
P5: The limited applicability of ML systems for 
the diagnosis of specific conditions will impede the 
implementation of ML systems in clinics. 
Value proposition. The value proposition is the 
third domain of the NASSS framework, we were able 
to concretize by analyzing the interviews. According to 
the experts, the implementation of ML systems could 
result in the creation of value for both the physicians 
and the patients (C-03, C-08, C-10).  
Implementing ML systems in their daily work 
enables physicians to improve the effectivity and 
efficiency of their diagnostics since they can base their 
decision on a broad data base that is evaluated within a 
few seconds (C-12): “If you have the choice among a 
pathologist who has already looked at 10,000 cuts […] 
compared to one who has created only 500 findings, 
whom would you chose? But […] AI has not only 
10,000 but 500,000 findings in memory” (C-06). In this 
regard, ML systems that are for example based on 
image recognition algorithms can surpass the ability of 
the human eye to capture details and patterns in X-rays 
[3]. If used as a second opinion, ML system thus 
increase the quality of physicians’ work (C-02, C-09).  
Also, patients could directly benefit from a decision 
that is faster and more informed if physicians use ML 
systems for diagnostics (C-08, C-12). We thus propose:  
P6: The additional value for physicians and patients 
created through ML will facilitate the implementation 
of ML systems in clinics. 
Patient data. During the interviews, nearly all 
experts stated the availability of patient data as crucial 
for both the readiness of a clinic to adopt and 
implement ML systems for diagnostics. In this regard, 
patient data has to be available to develop and train the 
ML system in the first place and subsequently retrain it 
during use. This factor comprises certain sub-factors 
which are described in the following. 
According to the experts, most of the clinics 
generate high volumes of patient data through their 
daily diagnostic processes (C-03, S-01), which is 
basically positive since an appropriate ‘amount of data’ 
are needed to train ML systems [8].  
However, interviewing the experts revealed that 
medical patient data are usually provided in a variety 
of ‘proprietary data formats’ since many disparate 
clinical legacy systems from different suppliers have to 
interact in order to enable physicians to provide 
laboratory tests, diagnostic images (e.g. X-rays), or 
clinical notes. These proprietary data formats are often 
difficult or impossible to convert, making the 
generation of consistent formats highly problematic 
(C-03). The problem of differing data formats in clinics 
has already been recognized outside the ML context, 
e.g. when adopting cloud solutions in healthcare 
environments [e.g. 48]. Nevertheless, it is particularly 
critical for the introduction and use of ML systems that 
the patient data can be processed in order to be able to 
train and retrain the system. Although first research has 
been conducted to allow for the transformation of 
different medical data types in one format [26], most 
clinics have not yet been able to implement unified 
standards for patient data in order to enable the 
processing and analysis by ML systems.  
Furthermore, patient data are often stored in 
‘unstructured file types’ such as image, text, or video. 
Experts raised the concern that physician letters are 
frequently written in free text formats, which are filled 
with synonyms and can be individually interpreted. For 
example, personal formulations are used, such as the 
description of a tumor’s size as comparable to a walnut 
(C-01). Thus, the patient data are not only hard to 
harness and has to be transferred in a machine-readable 
format first (C-03), it also lacks common quality 
standards for patient data, impeding the extraction of 
generalizable patterns through ML. Clinics aiming to 
adopt ML systems to support their diagnostics should 
therefore establish a common language that physicians 
apply when creating free texts. Such efforts are already 
being driven by some national initiatives (C-12).  
Moreover, it has been strongly emphasized by the 
experts, that clinics, which want to use patient data to 
train ML systems, need to anonymize the sensitive data 
before processing it through an ML system (C-11). 
However, ‘anonymizing data’ might remove valuable 
information, which could be important regarding the 
final diagnosis. For instance, information about a 




disease is more prevalent regionally (C-11). Therefore, 
it is necessary for clinics to find ways to anonymize 
patient data without losing relevant correlations. First 
steps are already being taken in technical research to 
balance the protection against the quality of sensitive 
data effectively [e.g. 36].  
In addition, there is no ‘basic truth’ for a healthy 
patient as the human body is a highly complex, not 
fully understood system. Therefore, no standard for an 
entirely healthy human can be determined as every 
medical examination could be influenced by the 
selection of medical measures, undiscovered diseases, 
or environmental conditions (S-02). In this context, 
analyzing the quality of patient data is problematic: “A 
standard for ‘what is healthy’ is not defined” (S-02).  
According to the experts, the selection of the right 
training data is especially important in a healthcare 
context, since wrong diagnoses may have an impact on 
patients’ lives. This leads to another aspect of patient 
data, which has to be considered: their 
‘representativeness’. Patients of clinics vary in many 
aspects—from an outer perspective (e.g. age, gender, 
hair color) as well as from the inner functioning (e.g. 
size of organs, blood values). If ML systems are 
predominantly trained based on a demographically or 
regionally distorted database, false conclusions could 
be drawn by the system. In this context, an expert 
raised the example of a ML system supporting the 
detection of skin melanomas, which is mainly trained 
on a sample of patients with a similar phenotype. 
Therefore, this pre-trained ML system cannot be easily 
transferred to patients of other ages or with other skin 
pigmentation (C-01). As training data for supervised 
learning need to be labelled by humans, the same could 
be said regarding the expertise and working philosophy 
of physicians, which could be highly heterogeneous 
depending on physician’s knowledge state and working 
environment (C-07, C-10). 
Another aspect that influences the availability of 
ML systems in clinics is the ‘digitization of patient 
data’. Even though high volumes of data are generated, 
many processes in clinics are still paper-based 
impeding the availability of patient data in a digitized 
form: “Data are often not digitized, much is still in 
paper files, not structured, which means that the data 
availability is really extremely [...] poor" (C-03). This 
observation is in line with prior research concerning 
clinics who are lagging behind at using digitized 
technologies [e.g. 21]. As a consequence, the 
interviewed experts see the integration of an electronic 
medical record system as a prerequisite for the 
application of ML systems (C-12, C-03).  
Additionally, the availability of patient data is 
limited due to difficulties of ‘patient data sharing’. 
Although some experts state that their clinics already 
have some special data networks in place, most 
healthcare organizations are still not connected. To 
enhance the availability of patient data in order to train 
ML systems, more secure internal (within clinic) and 
external data networks (e.g. clinic-to-primary care) 
should be established (C-03).  
The availability of patient data is not only a factor 
that decides on the readiness of a clinic to adopt ML 
systems, but must also be guaranteed during 
implementation phase in order to feed and retrain ML 
systems. Therefore, we identify the availability of 
patient data as an overarching factor as it influences 
both the readiness and implementation phase: 
P7: The availability of large volumes of digitized 
patient data (that are structured, uniformly formatted, 
anonymized, and representative) will facilitate the 
readiness of clinics to adopt and the implementation 
of ML systems in clinics. 
 
5. Conclusion  
 
ML has an impact on all areas of human life 
including the healthcare system. In this regard, ML 
systems offer the opportunity to make diagnostics more 
efficient and informed. However, in order to harness 
ML for such an application, clinics need to deeply 
integrate ML systems into their clinical practice—a 
challenge that most clinics have not yet been able to 
overcome [24]. Since clinics own highly individual, 
human-oriented processes, it is crucial for IS 
researchers to reflect on this specific context [11].  
The prior research is lagging behind to provide 
empirically proven factors that influence the 
integration of ML systems in clinics for diagnostic 
processes. To address this shortcoming, we set up a 
qualitative study and structured our findings in an 
integrated overview based on the frameworks TOE and 
NASSS. Before we discuss our contributions to theory 
and practice, it is necessary to clarify the limitations of 
this study. Since we pursued a qualitative approach, 
our results are based on the expertise of 15 
interviewees. In order to counter potential problems of 
generalizability, we have applied various criteria to 
ensure rigor and trustworthiness of our study (e.g. 
theoretical saturation, triangulation, inclusion of 
multiple medical disciplines). Nevertheless, it might be 
interesting for further research to perform a 
quantitative study to verify the stated propositions and 
validate the proposed framework (i.e. P1-P7). 
Furthermore, the interviews were conducted in 
Germany only. Since the healthcare systems vary 
across nations, interviewing experts from other regions 
could lead to differing results. In addition, the rapid 
development of increasingly advanced ML algorithms 




augment but automate diagnostic processes. 
Investigating automated diagnostics could produce 
different findings, even though the results obtained in 
this study could provide first indications. Nevertheless, 
our study makes several important contributions. To 
begin with, it could be shown that the TOE and 
NASSS framework can be applied, but have to be 
integrated and expanded in order to explain the full 
adoption process of ML systems for diagnostics in 
clinics. On this basis, we are the first to provide an 
integrative overview of readiness and implementation 
factors regarding ML systems in clinics. The overview 
includes three propositions that affect the readiness of 
a clinic to adopt ML systems and three that impact the 
subsequent implementation phase to put these systems 
into clinical use. Availability of patient data is found to 
be overarching as it influences both the readiness and 
implementation phase. Therefore, we contribute to 
adoption research in health informatics, which has 
recently called to look beyond the mere readiness to 
adopt HIT in healthcare organizations and to 
emphasize its subsequent implementation [17]. In 
addition, our study holds important practical 
implementations. In this regard, the key findings could 
guide medical directors of clinics aiming to integrate 
ML systems within their diagnostic processes. For 
example, clinics are still lacking strategies to 
implement unified patient data formats, even though 
research efforts in this area already exist. Thus, our 
study could lay a foundation to avoid pitfalls that could 
occur during the readiness or implementation phase of 
ML systems in a medical environment. 
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